Group One Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-117
Closed -$12.7K 8203
2023
Q3
$12.7K Hold
117
﹤0.01% 6196
2023
Q2
$16.9K Hold
117
﹤0.01% 6093
2023
Q1
$16.4K Hold
117
﹤0.01% 5639
2022
Q4
$17.3K Buy
+117
New +$21.3K ﹤0.01% 5687
2022
Q1
Sell
-137
Closed -$29K 8731
2021
Q4
$29K Buy
137
+127
+1,270% +$36K ﹤0.01% 6753
2021
Q3
$3K Sell
10
-5
-33% -$1.76K ﹤0.01% 7893
2021
Q2
$7K Hold
15
﹤0.01% 7670
2021
Q1
$8K Buy
+15
New +$10.8K ﹤0.01% 7133
2019
Q4
Sell
-160
Closed -$29K 5628
2019
Q3
$29K Buy
+160
New +$41.7K ﹤0.01% 4222
2017
Q2
Sell
-4
Closed -$4K 5093
2017
Q1
$4K Sell
4
-2
-33% -$1.88K ﹤0.01% 4342
2016
Q4
$6K Buy
+6
New +$6.2K ﹤0.01% 4075
2016
Q2
Sell
-67
Closed -$117K 4956
2016
Q1
$117K Buy
+67
New +$107K ﹤0.01% 2722
2015
Q3
Sell
-61
Closed -$166K 5201
2015
Q2
$166K Buy
+61
New +$158K ﹤0.01% 2672
2015
Q1
Sell
-13
Closed -$35K 5196
2014
Q4
$35K Sell
13
-76
-85% -$196K ﹤0.01% 3619
2014
Q3
$243K Sell
89
-60
-40% -$195K ﹤0.01% 2224
2014
Q2
$516K Buy
149
+102
+217% +$363K 0.01% 1625
2014
Q1
$170K Sell
47
-66
-58% -$260K ﹤0.01% 2580
2013
Q4
$427K Sell
113
-6
-5% -$21.6K 0.01% 1783
2013
Q3
$387K Sell
119
-14
-11% -$40.9K 0.01% 1833
2013
Q2
$337K Buy
+133
New +$331K 0.01% 1685

Other funds holding TRIB

Group One Trading's TRIB Position: Q4 2023 in Review

Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 111 shares — an estimated $12.2K sold.

Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 24 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

  • Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 111 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
  • Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
  • 24 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.